Professional
Added to YB: 2024-04-12
Pitch date: 2024-03-31
KVUE [bullish]
Kenvue Inc.
-5.64%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America.
Market Cap
$35.8B
Pitch Price
$19.77
Price Target
N/A
Dividend
4.44%
EV/EBITDA
12.20
P/E
25.01
EV/Sales
2.92
Sector
Personal Care Products
Category
value
Show full summary:
Oakmark Fund New Position: Kenvue Inc.
KVUE: Leading consumer health co w/ iconic brands (Neutrogena, Listerine, Tylenol, Band-Aid). Spin-off from JNJ in May '23. Recent litigation & share losses = attractive 16.5x P/E (discount to peers). Opportunity to boost efficiency, reinvest savings in R&D & marketing to drive growth & brand equity.
Read full article (1 min)